Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
10.54
+7.35 (230.41%)
At close: Mar 27, 2026, 4:00 PM EDT
8.39
-2.15 (-20.40%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $7.76 million as of March 27, 2026. Its market cap has increased by 150.28% in one year.
Market Cap
7.76M
Enterprise Value
7.84M
1-Year Change
150.28%
Ranking
Category
Stock Price
$10.54
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $7.76M, a decrease of -36.92%. That is a compound annual growth rate of -6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 7.50M | 200.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.32M |
| XORTX Therapeutics | 3.25M |
| Galmed Pharmaceuticals | 3.22M |
| Enveric Biosciences | 2.59M |
| Oragenics | 2.51M |
| Adial Pharmaceuticals | 2.46M |
| Calidi Biotherapeutics | 2.02M |
| Bone Biologics | 2.00M |